Capital Impact Advisors, LLC Guardant Health, Inc. Transaction History

Capital Impact Advisors, LLC

$75.1 Million
Q1 2024

A detailed history of Capital Impact Advisors, LLC transactions in Guardant Health, Inc. stock. As of the latest transaction made, Capital Impact Advisors, LLC holds 16,619 shares of GH stock, worth $458,850. This represents 0.46% of its overall portfolio holdings.

Number of Shares

16,619

Previous 35,219 52.81%

Holding current value

$458,850

Previous $952,000 64.08%

% of portfolio

0.46%

Previous 1.28%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$17.13 - $26.91 $318,618 - $500,526	-18,600 Reduced 52.81%	16,619 $342,000
Q4 2023 Feb 14, 2024	BUY	$21.58 - $29.5 $535,119 - $731,511	24,797 Added 237.93%	35,219 $952,000
Q2 2023 Aug 14, 2023	BUY	$20.94 - $38.01 $22,175 - $40,252	1,059 Added 11.31%	10,422 $373,000
Q1 2023 May 23, 2023	BUY	$22.92 - $33.76 $214,599 - $316,094	9,363 New	9,363 $219,000
Q4 2021 Feb 14, 2022	SELL	$88.71 - $120.43 $1.51 Million - $2.04 Million	-16,975 Closed	0 $0

Q3 2021 Nov 15, 2021	SELL	$98.77 - $132.17 $417,500 - $558,682	-4,227 Reduced 19.94%	16,975 $2.12 Million
Q2 2021 Aug 17, 2021	BUY	$109.77 - $165.68 $1.4 Million - $2.12 Million	12,797 Added 152.25%	21,202 $2.63 Million
Q1 2021 May 18, 2021	SELL	$127.04 - $179.1 $1.85 Million - $2.6 Million	-14,538 Reduced 63.37%	8,405 $1.28 Million
Q3 2020 Nov 13, 2020	SELL	$80.32 - $111.8 $803,199 - $1.12 Million	-10,000 Reduced 30.36%	22,943 $2.57 Million
Q1 2020 May 15, 2020	BUY	$59.04 - $88.81 $75,098 - $112,966	1,272 Added 4.02%	32,943 $2.29 Million
Q4 2019 Feb 13, 2020	BUY	$59.49 - $82.78 $694,962 - $967,035	11,682 Added 58.44%	31,671 $2.48 Million
Q2 2019 Jul 19, 2019	BUY	$63.94 - $91.11 $1.28 Million - $1.82 Million	19,989 New	19,989 $1.68 Million

Others Institutions Holding GH

# of Institutions

310

Shares Held

110M

Call Options Held

2.51M

Put Options Held

1.7M

View Full List

About Guardant Health, Inc.

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $2.82B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

More about GH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Impact Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Impact Advisors, LLC with notifications on news.

Account

Capital Impact Advisors, LLC Guardant Health, Inc. Transaction History